AUPR311601A0 - Matrix gene expression in chondrogenesis - Google Patents

Matrix gene expression in chondrogenesis

Info

Publication number
AUPR311601A0
AUPR311601A0 AUPR3116A AUPR311601A AUPR311601A0 AU PR311601 A0 AUPR311601 A0 AU PR311601A0 AU PR3116 A AUPR3116 A AU PR3116A AU PR311601 A AUPR311601 A AU PR311601A AU PR311601 A0 AUPR311601 A0 AU PR311601A0
Authority
AU
Australia
Prior art keywords
chondrogenesis
gene expression
matrix gene
matrix
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR3116A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADP PHARMACEUTICAL Pty Ltd
University of Sydney
Original Assignee
ADP PHARMACEUTICAL Pty Ltd
University of Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADP PHARMACEUTICAL Pty Ltd, University of Sydney filed Critical ADP PHARMACEUTICAL Pty Ltd
Priority to AUPR3116A priority Critical patent/AUPR311601A0/en
Publication of AUPR311601A0 publication Critical patent/AUPR311601A0/en
Priority to NZ528202A priority patent/NZ528202A/en
Priority to US10/468,091 priority patent/US20040157329A1/en
Priority to PCT/AU2002/000163 priority patent/WO2002064625A1/en
Priority to CA002440743A priority patent/CA2440743A1/en
Priority to EP02700018A priority patent/EP1370579A4/en
Priority to JP2002564954A priority patent/JP2004537274A/ja
Priority to NO20033624A priority patent/NO20033624L/no
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AUPR3116A 2001-02-15 2001-02-15 Matrix gene expression in chondrogenesis Abandoned AUPR311601A0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AUPR3116A AUPR311601A0 (en) 2001-02-15 2001-02-15 Matrix gene expression in chondrogenesis
NZ528202A NZ528202A (en) 2001-02-15 2002-02-15 Matrix gene expression in chondrogenesis
US10/468,091 US20040157329A1 (en) 2001-02-15 2002-02-15 Matrix gene expression in chondrogenesis
PCT/AU2002/000163 WO2002064625A1 (en) 2001-02-15 2002-02-15 Matrix gene expression in chondrogenesis
CA002440743A CA2440743A1 (en) 2001-02-15 2002-02-15 Matrix gene expression in chondrogenesis
EP02700018A EP1370579A4 (en) 2001-02-15 2002-02-15 MATRIX GENE EXPRESSION IN CHONDROGENESIS
JP2002564954A JP2004537274A (ja) 2001-02-15 2002-02-15 軟骨形成におけるマトリックス遺伝子発現
NO20033624A NO20033624L (no) 2001-02-15 2003-08-14 Matrise genekspresjon i chondrogenese

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR3116A AUPR311601A0 (en) 2001-02-15 2001-02-15 Matrix gene expression in chondrogenesis

Publications (1)

Publication Number Publication Date
AUPR311601A0 true AUPR311601A0 (en) 2001-03-08

Family

ID=3827137

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR3116A Abandoned AUPR311601A0 (en) 2001-02-15 2001-02-15 Matrix gene expression in chondrogenesis

Country Status (8)

Country Link
US (1) US20040157329A1 (https=)
EP (1) EP1370579A4 (https=)
JP (1) JP2004537274A (https=)
AU (1) AUPR311601A0 (https=)
CA (1) CA2440743A1 (https=)
NO (1) NO20033624L (https=)
NZ (1) NZ528202A (https=)
WO (1) WO2002064625A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113096736A (zh) * 2021-03-26 2021-07-09 北京源生康泰基因科技有限公司 一种基于纳米孔测序的病毒实时自动分析方法及系统

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004026944D1 (de) * 2003-03-28 2010-06-10 Fujifilm Mfg Europe Bv RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
CN1838968A (zh) 2003-08-08 2006-09-27 艾伯吉尼斯公司 针对甲状旁腺激素(pth)之抗体和其用途
WO2005106495A1 (en) * 2004-05-04 2005-11-10 Pharmacia & Upjohn Company Llc Procollagen ii biomarkers and methods
US20080082170A1 (en) * 2006-09-29 2008-04-03 Peterman Marc M Apparatus and methods for surgical repair
ES2678211T3 (es) 2012-03-27 2018-08-09 Ventana Medical Systems, Inc. Conjugados de señalización y procedimientos de uso
WO2014093836A1 (en) * 2012-12-13 2014-06-19 University Of Georgia Research Foundation, Inc. Ossification-inducing composition and methods of use thereof
JP2020502056A (ja) * 2016-11-13 2020-01-23 イマジン ファーマ 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法
US20230210942A1 (en) * 2018-01-09 2023-07-06 Imagine Pharma Llc Methods and compositions for modulating endothelial cell dysfunction
CN113201487A (zh) * 2021-07-06 2021-08-03 广东先康达生物科技有限公司 成软骨细胞培养基及成软骨细胞的培养方法
CN113563458B (zh) * 2021-07-19 2023-07-21 嘉兴恒杰生物制药股份有限公司 一种非变性ii型胶原蛋白的制备方法
JP2024532985A (ja) * 2021-09-22 2024-09-12 イマジン ファーマ、エルエルシー １型糖尿病患者膵臓組織からインスリンおよびグルカゴン分泌細胞を増殖させるための組成物および方法およびその治療的使用
CN119504941B (zh) * 2024-12-03 2026-01-13 中国海洋大学 一种富含海洋肽钙螯合物的骨健康压片糖果及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080891A (en) * 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US6159464A (en) * 1990-12-20 2000-12-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints
JP2001512013A (ja) * 1997-08-01 2001-08-21 ジェンセット 前立腺に発現される分泌タンパク質の５’ｅｓｔ
US20030144475A1 (en) * 1999-12-06 2003-07-31 Seishi Kato Human protein and cdna

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113096736A (zh) * 2021-03-26 2021-07-09 北京源生康泰基因科技有限公司 一种基于纳米孔测序的病毒实时自动分析方法及系统

Also Published As

Publication number Publication date
EP1370579A4 (en) 2005-05-11
EP1370579A1 (en) 2003-12-17
WO2002064625A1 (en) 2002-08-22
NO20033624L (no) 2003-10-10
US20040157329A1 (en) 2004-08-12
NZ528202A (en) 2005-09-30
JP2004537274A (ja) 2004-12-16
CA2440743A1 (en) 2002-08-22
NO20033624D0 (no) 2003-08-14

Similar Documents

Publication Publication Date Title
AU2002349784A1 (en) Nf-kappab activating genes
AU2002306374A1 (en) Genes with ES cell-specific expression
AU2001272482A1 (en) Osteolevin gene polymorphisms
AU2001245987A1 (en) Compositions and methods for gene therapy
AUPR311601A0 (en) Matrix gene expression in chondrogenesis
AU2002365188A1 (en) Nucleic acid delivery and expression
AUPQ262599A0 (en) Gene expression
AU2003281867A1 (en) Antisense nucleic acids
AU2001270478A1 (en) Gene expression in biological conditions
AU2003217222A1 (en) In vivo gene transfer
AU2001240103A1 (en) Reproduction-specific genes
AU2001247444A1 (en) Erbeta-mediated gene expression
AUPQ749100A0 (en) New epilespy gene
AU2153401A (en) Gene expression in biological conditions
AU2001285743A1 (en) Adipose-related gene
AU7567101A (en) Gene expression system
AU2003275946A1 (en) Gene expression in biological conditions
AU2003294705A1 (en) NtSM GENE
AU2002307963A1 (en) Genetic typing
AU6871900A (en) Tsg-like gene
AU1870000A (en) Gene therapy-2
AUPQ513900A0 (en) Matrix gene expression in chondrogenesis
AU2003267384A1 (en) Bhyd gene
AUPP819799A0 (en) Matrix gene expression in chondrogenesis
AU2002243307A1 (en) Gene therapy using tgf-beta